SALT LAKE CITY–(BUSINESS WIRE)–Recursion, an industry leader in artificial intelligence for drug discovery and development, today announced the appointment of Sharath Hegde, Ph.D. as its Chief Scientific Officer. Dr. Hegde has more than 28 years of leadership experience at the intersection of drug discovery and clinical development and has seen multiple drugs from discovery through FDA approval.
“I am incredibly excited to join the talented team at Recursion and become a part of its vibrant, collaborative culture,” said Dr. Hegde. “The application of AI to image-based technologies is well-proven in other industries, and Recursion is leading the way by leveraging its state-of-the-art machine learning and deep biological expertise to understand human disease. I am convinced that Recursion’s approach has the potential to create a paradigm shift in the discovery and development of transformative medicines, particularly in those cases where traditional methods have eluded effective treatments for decades.”